In this Issue:
Psoriasis and the risk of depression
Conventional systemic and biological treatments for psoriasis
Efficacy and safety of apremilast
Malignancies and hospitalised infections in psoriasis
Long-term etanercept in children and adolescents
Biologics: adverse effects in psoriasis
Patient’s willingness to accept side-effect risks
Calcipotriol/betamethasone; efficacy, safety and patient acceptability
Subcutaneous methotrexate for severe recalcitrant psoriasis
Clinical symptoms and severity in psoriasis
Correlation between VEGF and subclinical atherosclerosis
Please login below to download this issue (PDF)